Funding
← Back to your selection

DCVC

Activity from announced rounds

Activity in this selectionUnited States

DCVC is an investment firm identified by TypeSafe AI as an existing investor and by its own communications as a backer of Shennon Biotechnologies.

Recorded funding activity

TypeSafe turns unstructured inputs into typed decisions and probability scores for automated software. Shennon develops T-cell engager therapies for solid tumors. Separate TypeSafe financings remain separate events under one investor history.

Sources
Rounds participated in
9
Confirmed lead rounds
1
5 roles undisclosed
New companies
8
First participation on record · 1 follow-on
Funding in participating rounds
$1.3B
8 disclosed · full round size, not this investor’s share

By stage

Series A3
Series B2
Undisclosed2
Seed1
Series C+1

By primary sector

Biotech3
AI2
Agritech1
Climate tech1
Defense tech1
1 more
Hardware1

By country

United States9

Rounds

9 in this selection
TypeSafe AI

Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.

$870MSeries A
Participant
Rainmaker

Rainmaker develops cloud-seeding technology and atmospheric research tools to increase freshwater supply.

$100MSeries B
Participant
TypeSafe AI

Developer infrastructure that turns unstructured inputs into typed decisions and probability scores for automated software workflows.

$40MSeed
Lead
Shennon Biotechnologies

Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors.

$12MFunding
Participant
Sabanto

Sabanto develops autonomous retrofit technology for agricultural equipment.

UndisclosedSeries B
Role not disclosed
Atom Computing

Develops large-scale neutral-atom quantum computers for fault-tolerant commercial and government applications

$100MSeries C
Role not disclosed
Kanvas Biosciences

Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy

$48MSeries A
Role not disclosed
Chariot Defense

Chariot Defense develops power-distribution systems for military use.

$34MSeries A
Role not disclosed
Proxima

Develops AI-driven drug discovery for proximity therapeutics

$80MUndisclosed
Role not disclosed